Lev has also announced plans to launch LevCare, a program designed to ensure that patients have ready access to Cinryze once it becomes commercially available in the US.
CuraScript and CVS Caremark will provide specialty pharmacy and specialty distribution services that deliver Cinryze directly to patients, clinics and physicians. FFF Enterprises will serve as Lev’s third party logistics provider and specialty distributor to supply Cinryze to hospitals, clinics and physicians.
LevCare, which will be administered by TheraCom, a division of CVS Caremark, will provide support services to patients and physicians, such as benefit coverage investigations, prior authorizations, case management and broad-based reimbursement assistance.
Judson Cooper, chairman of Lev, said: “By employing a ‘limited distribution model’ through the comprehensive, co-ordinated and integrated services of CuraScript, CVS Caremark, FFF Enterprises and LevCare, we will be well positioned to provide patients with broad access to Cinryze pending FDA approval.”